Pa. Groome et al., Glottic cancer in Ontario, Canada and the SEER areas of the United States:Do different management philosophies produce different outcome profiles?, J CLIN EPID, 54(3), 2001, pp. 301-315
Citations number
61
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
We compared the management and outcome of glottic cancer in Ontario, Canada
to that in the Surveillance, Epidemiology and End Results (SEER) Program a
reas in the United States to determine whether the greater use of primary r
adiotherapy with surgery reserved for salvage in Ontario was associated wit
h similar survival and better larynx retention rates than the U.S, approach
where primary surgery is used more often. Electronic, clinical and hospita
l data were linked to cancer registry data and supplemented by chart review
where necessary. Initial treatment and survival in patients diagnosed in t
he SEER areas from 1988 through 1994 were compared to patients from Ontario
diagnosed from 1982 through 1995. Actuarial laryngectomy rates were compar
ed for patients over 65 at diagnosis in the two regions. Analyses were cond
ucted over all cases and stratified by disease stage. In localized disease
(T1 or T2), conservative treatment was the most common initial treatment in
both regions, although total laryngectomy was used more often in SEER than
Ontario (6.2% vs. 0.2%, respectively, P < .001). In advanced disease (T3 o
r T4), total laryngectomy was more commonly used as initial treatment in SE
ER (62.9% vs. 21.0% in Ontario, P <less than or equal to> .001). Over all c
ases, the relative survival rate was 80% in Ontario at 5 years compared to
78% in SEER (P = .33). In localized disease, the relative survival rates we
re 4 to 5% higher in Ontario from the second year on, while in advanced dis
ease 2 to 3% higher rates in SEER did not approach statistical significance
. Actuarial laryngectomy rates at 3 years differed between the two regions,
with a 4% higher rate in SEER (P = .01). In localized disease, 12.6% of On
tario patients had a laryngectomy by 3 years post-diagnosis compared to 17.
9% in SEER (P = .05), In advanced disease, the rates were 63.3% and 79.2%,
respectively (P = .07). There are large differences in the management of gl
ottic cancer between the SEER areas of the U.S. and Ontario and no evidence
that a policy emphasizing radiotherapy with surgery reserved for salvage i
s associated with worse survival. Ultimate laryngectomy rates are lower in
Ontario for localized disease and may be lower for advanced disease. Conser
vation treatment should be used for localized disease while the treatment d
ecision in advanced disease may be especially sensitive to patient values f
or Voice retention Versus initial cure. (C) 2001 Elsevier Science Inc. All
rights reserved.